Ledger.Open graph →
SEC Form D · Amendment · filed July 1, 2021

Glympse Bio, Inc

Offering
$46.7M
Sold
$46.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (30)

Theresia Gouw · Cambridge, MADirectorGeorge Zachary · Cambridge, MADirectorFrancis Cuss · Cambridge, MADirectorStanley Lapidus · Cambridge, MADirectorRobert Langer · Cambridge, MADirectorAmy Schulman · Cambridge, MADirectorSteve Kafka · Cambridge, MADirectorCaroline Loew · Cambridge, MAExec · DirectorWendy W. Adamovich · 35 Cambridgepark Dr., Suite 10, MAExecStephen Carnes · Winter Park, FLDirectorJeff W. Wilson · Vancouver, British Columbia, CanadaDirectorStephen Fitzgerald · Concord, NHDirectorJordan Wan · Dover, DEDirectorJohn Wagner · LOS ANGELES, CADirectorMonika Mantilla · Coral Gables, FLDirectorJohn Wenger · VANCOUVER, British Columbia, CanadaDirectorJanice Price · LOS ANGELES, CAExec · DirectorJessica W. Atkinson · 35 Cambridgepark Dr., Suite 10, MAExecDhaval W. Gosalia · 35 Cambridgepark Dr., Suite 10, MAExecTracy E. Watkins · WELLSBORO, PADirectorThomas L. Rudy, Jr · WELLSBORO, PADirectorClark S. Frame · WELLSBORO, PAExec · DirectorRobert G. Loughery · WELLSBORO, PADirectorShelley L. D'Haene · WELLSBORO, PADirectorAaron K. Singer · WELLSBORO, PADirectorSusan E. Hartley · WELLSBORO, PADirectorStephen M. Dorwart · WELLSBORO, PADirectorJessica W. Atkinson · 35 Cambridgepark Dr., Suite 10, MAExecDhaval W. Gosalia · 35 Cambridgepark Dr., Suite 10, MAExecWendy W. Adamovich · 35 Cambridgepark Dr., Suite 10, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗